Oct. 30, 2026
CARLSBAD, CALIFORNIA — Lineage Cell Therapeutics announced that its experimental ReSonance (ANP1) cell therapy program for hearing loss has completed the development activities planned for the first year of its research collaboration with William Demant Invest (WDI), allowing the project to advance into its second year. The program is exploring whether transplanted auditory nerve cells could eventually improve hearing outcomes for
















